Bleeding patterns in recent postmenopausal outpatients with uterine myomas: Comparison between two regimens of HRT

Maturitas

Volumn 29, Issue 3, 1998, Pages 261-264

  De Aloysio, Domenico ^a   Altieri, Paola ^a   Penacchioni, Paola ^a   Salgarello, Matteo ^a   Ventura, Vito ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Conjugated equine estrogens; Cycle control; HRT; Leiomyomas; Postmenopause; Tibolone

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; TIBOLONE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LEIOMYOMA; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY; UTERUS BLEEDING; UTERUS MYOMA;

ANABOLIC AGENTS; ESTROGENS, CONJUGATED (USP); FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LEIOMYOMA; MEDROXYPROGESTERONE 17-ACETATE; MENOPAUSE; MENSTRUAL CYCLE; MIDDLE AGED; NORPREGNENES; PROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 0032540750     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(98)00014-0     Document Type: Article

References (9)

1. Murphy A.A., Morales A.J., Kettel L.M., Yen S.S.C. Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect. Fertil Steril. 64(1):1995;187-190.
2. Harrison-Woolrych M., Robinson R. Fibroid growth in response to high-dose progestogen. Fertil Steril. 64(1):1995;191-192.
3. Rein M.S., Barbieri R.L., Friedman A.J. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 172(1):1995;14-18.
4. Rein M.S., Friedman A.J., Stuart J.M., MacLaughlin D.T. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril. 53:1990;1018-1023.
5. Andersen J., Grine E., Eng C.L.Y.et al. Expression of connexin-43 in human myometrium and leiomyoma. Am J Obstet Gynecol. 169:1993;1266-1276.
6. Akkad A.A., Habiba M.A., Ismail N., Abrams K., Al-Azzawi F. Abnormal uterine bleeding on hormone replacement: the importance of intrauterine structural abnormalities. Obstet Gynecol. 86(3):1995;330-334.
7. Thomas E.J. Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids. Br J Obstet Gynaecol. 103(S14):1996;18-21.
8. Archer D.F., Pickar J.H., Bottiglioni F.et al. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol. 83(5):1994;686-692.
9. Rymer J., Fogelman I., Chapman M.G. The incidence of vaginal bleeding with tibolone treatment. Br J Obstet Gynaecol. 101:1994;53-56.